Capricor Therapeutics

1 follower

‌

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.

Industries

Headquarters

Stage

Employees

Links

Org chart

View full screen

Linda Marbán

President, CEO & Director

Linda Marbán

Collapse

Aj Bergmann

CFO

Kristi A. H. Elliott

Chief Science Officer

Mark Awadalla

Vice President Clinical Research & Development Operations

Yushi Feng

VP of Regulatory Affairs

Jonathan Tayco

VP, Program Management & Business Operations

Cecelia Smiley-Adams

Sr. Manager Quality Assurance Clinical

Joe Z.

Senior IP Counsel

Teams

View all

Board of Directors

4 members

Leadership Team

3 members

CEO and Executive Team

2 members

Discover similar companies

Kymera Therapeutics

3 followers

Cartesian Therapeutics

1 follower

Tempus Labs

12 followers

Ultragenyx Pharmaceutical

5 followers

Biogen

92 followers